194 related articles for article (PubMed ID: 23645479)
1. Warfarin users prone to coagulopathy in first 30 days after hospital discharge from gastric bypass.
Bechtel P; Boorse R; Rovito P; Harrison TD; Hong J
Obes Surg; 2013 Oct; 23(10):1515-9. PubMed ID: 23645479
[TBL] [Abstract][Full Text] [Related]
2. Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy.
Strong AT; Sharma G; Nor Hanipah Z; Tu C; Brethauer SA; Schauer PR; Cetin D; Aminian A
Surg Obes Relat Dis; 2018 May; 14(5):700-706. PubMed ID: 29496441
[TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
[TBL] [Abstract][Full Text] [Related]
5. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
[TBL] [Abstract][Full Text] [Related]
6. Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy.
Irwin AN; McCool KH; Delate T; Witt DM
Pharmacotherapy; 2013 Nov; 33(11):1175-83. PubMed ID: 23744816
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery.
Harkin M; Shaddix BP; Neely SB; Peek LA; Stephens K; Barker P; McMullan L; Gormley A; Johnson PN
Am J Health Syst Pharm; 2020 Jun; 77(13):1018-1025. PubMed ID: 32470108
[TBL] [Abstract][Full Text] [Related]
8. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.
Shalansky S; Lynd L; Richardson K; Ingaszewski A; Kerr C
Pharmacotherapy; 2007 Sep; 27(9):1237-47. PubMed ID: 17723077
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Warfarin Dosages and International Normalized Ratios Before and After Roux-en-Y Gastric Bypass Surgery.
Steffen KJ; Wonderlich JA; Erickson AL; Strawsell H; Mitchell JE; Crosby RD
Pharmacotherapy; 2015 Sep; 35(9):876-80. PubMed ID: 26406775
[TBL] [Abstract][Full Text] [Related]
10. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
Schultz KT; Bungard TJ
Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
12. Evaluating warfarin management by pharmacists in a community teaching hospital.
Chilipko AA; Norwood DK
Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic and thromboembolic complications after bariatric surgery in patients receiving chronic anticoagulation therapy.
Mourelo R; Kaidar-Person O; Fajnwaks P; Roa PE; Pinto D; Szomstein S; Rosenthal RJ
Obes Surg; 2008 Feb; 18(2):167-70. PubMed ID: 18185962
[TBL] [Abstract][Full Text] [Related]
14. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
Subherwal S; Peterson ED; Chen AY; Roe MT; Washam JB; Gage BF; Bach RG; Bhatt DL; Wiviott SD; Lopes RD; Alexander KP; Wang TY
Circulation; 2012 Mar; 125(11):1414-23. PubMed ID: 22319105
[TBL] [Abstract][Full Text] [Related]
15. Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER.
Brennan JM; Alexander KP; Wallace A; Hodges AB; Laschinger JC; Jones KW; O'Brien S; Webb LE; Dokholyan RS; Peterson ED
J Heart Valve Dis; 2012 Jan; 21(1):78-87. PubMed ID: 22474747
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Warfarin Use in Post-Bariatric Surgery Patients: Cases Compiled From a Literature Review.
Patel PH; Ho T; Upadhyay SM
Ann Pharmacother; 2023 Feb; 57(2):193-197. PubMed ID: 35699512
[TBL] [Abstract][Full Text] [Related]
17. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
Garcia DA; Regan S; Crowther M; Hylek EM
J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.
Cao H; Wu J; Zhang J
Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134
[TBL] [Abstract][Full Text] [Related]
19. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Shapiro NL; Durr EA; Krueger CD
Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
[TBL] [Abstract][Full Text] [Related]
20. Safety of warfarin dosing in the intensive care unit following the Fontan procedure.
Thomas CA; Taylor K; Schamberger MS; Rotta AT
Congenit Heart Dis; 2014; 9(4):361-5. PubMed ID: 25247218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
